Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques

Alexandra M. Ortiz, Jacob K. Flynn, Sarah R. DiNapoli, Ivan Vujkovic-Cvijin, Carly E. Starke, Stephen H. Lai, MacKenzie K.E. Long, Ornella Sortino, Carol L. Vinton, Joseph C. Mudd, Leslie Johnston, Kathleen Busman-Sahay, Yasmine Belkaid, Jacob D. Estes, Jason M. Brenchley

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Abstract

Intestinal microbial dysbiosis has been described in individuals with an HIV-1 infection and may underlie persistent inflammation in chronic infection, thereby contributing to disease progression. Herein, we induced an HIV-1-like intestinal dysbiosis in rhesus macaques (Macaca mulatta) with vancomycin treatment and assessed the contribution of dysbiosis to SIV disease progression. Dysbiotic and control animals had similar disease progression, indicating that intestinal microbial dysbiosis similar to that observed in individuals with HIV is not sufficient to accelerate untreated lentiviral disease progression.

Original languageEnglish (US)
Pages (from-to)1313-1316
Number of pages4
JournalNature medicine
Volume24
Issue number9
DOIs
StatePublished - Sep 1 2018

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Experimental microbial dysbiosis does not promote disease progression in SIV-infected macaques'. Together they form a unique fingerprint.

Cite this